CalciMedica, Inc.
CALC· Nasdaq
Filed Nov 13, 2024 · 10-Q · 44 days after period end · 0000950170-24-126296
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Net Income | -$5.62M | -$4.62M | -$2.58M | -$7.99M |
| EPS Diluted | -$0.50 | -$0.82 | -$31.04 | -$0.38 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CalciMedica, Inc. · CIK 1534133 · Engraved from SEC EDGAR
ended Sep 30, 2024 · filed Nov 13, 2024 · 44 d after period end